Skip to main content
. 2022 Oct 4;9:976844. doi: 10.3389/fcvm.2022.976844

FIGURE 1.

FIGURE 1

Nomogram for 1-year MACE prognosis in coronary heart disease (CHD) patients combined with AHF. The nomogram was developed in the primary cohort, with the Diabetes, HF history, NYHA ≥ 3, NT-proBNP, Lp-PLA2, and Hcy incorporated.